MAPT and early-onset autosomal dominant Alzheimer disease: We also evaluated the impact of 80 mM of cinnamaldehyde on the lifespan of three groups of non-Alzheimer disease parental control flies (non-AD Aβ42, Gal4elav-C155, and non-AD MAPT).